tréosulfan
Fri, 02 Jun 2023 16:51:10 -0400
Italiano
Fri, 02 Jun 2023 16:51:10 -0400
Wed, 31 May 2023 15:13:12 -0400
Tue, 30 May 2023 16:17:10 -0400
Opdualag (nivolumab et rélatlimab) est indiqué dans le traitement du mélanome non résécable ou métastatique chez l'adulte et l'enfant (12 ans ou plus, poids d'au moins 40 kg).
Tue, 30 May 2023 10:13:20 -0400
Mon, 29 May 2023 12:12:10 -0400
Mon, 29 May 2023 12:12:08 -0400
The FDA is requiring updates to the Boxed Warning and other information to ensure the prescribing information is made consistent across the entire class of these medicines to address continuing concerns of misuse, abuse, addiction, and overdose of prescription stimulants.
Thu, 25 May 2023 12:53:40 -0400
Thu, 25 May 2023 09:46:12 -0400
Thu, 25 May 2023 07:40:03 -0400
80.211.154.110